Lunai Bioworks, Inc. (LNAI)
2.49
+0.23
(+10.18%)
USD |
NASDAQ |
Jun 11, 13:41
Lunai Bioworks SG&A Expense (Quarterly) : 1.421M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.421M |
| December 31, 2025 | 1.766M |
| September 30, 2025 | 2.410M |
| June 30, 2025 | 4.001M |
| March 31, 2025 | 4.225M |
| December 31, 2024 | 4.353M |
| September 30, 2024 | 5.301M |
| June 30, 2024 | 4.999M |
| March 31, 2024 | 7.652M |
| December 31, 2023 | 3.616M |
| September 30, 2023 | 8.290M |
| June 30, 2023 | 2.952M |
| March 31, 2023 | 3.796M |
| December 31, 2022 | 4.013M |
| September 30, 2022 | 4.557M |
| June 30, 2022 | 3.160M |
| March 31, 2022 | 2.790M |
| December 31, 2021 | 4.155M |
| September 30, 2021 | 4.467M |
| June 30, 2021 | 2.079M |
| March 31, 2021 | 1.944M |
| December 31, 2020 | 1.94M |
| September 30, 2020 | 1.778M |
| June 30, 2020 | 1.498M |
| March 31, 2020 | 1.487M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.235M |
| September 30, 2019 | 1.869M |
| June 30, 2019 | 1.521M |
| March 31, 2019 | 1.952M |
| December 31, 2018 | 3.580M |
| September 30, 2018 | 1.252M |
| June 30, 2018 | 0.8286M |
| March 31, 2018 | 2.339M |
| December 31, 2017 | 1.057M |
| September 30, 2017 | 0.4682M |
| June 30, 2017 | 0.6291M |
| March 31, 2017 | 0.3312M |
| December 31, 2016 | 0.5314M |
| September 30, 2016 | 0.8314M |
| June 30, 2016 | 0.4785M |
| March 31, 2016 | 0.274M |
| December 31, 2015 | 0.3386M |
| September 30, 2015 | 0.2357M |
| March 31, 2015 | 0.665M |
| December 31, 2014 | 0.8606M |
| September 30, 2014 | 0.3655M |
| June 30, 2014 | 0.5009M |
| June 30, 2013 | 0.0025M |
| March 31, 2013 | 0.0094M |
| December 31, 2012 | 0.0096M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 6.86M |
| Amgen, Inc. | 1.602B |
| BioCryst Pharmaceuticals, Inc. | 94.55M |
| Imunon, Inc. | 1.969M |
| Curis, Inc. | 5.07M |